Position in KRYS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$5,946
+$1,813 QoQ
Shares Held
16
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#374
of 419 holders
Holding Since
Dec 2021
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bell Investment Advisors, Inc holds $389,495 across 65 Biotechnology names. KRYS ranks #16 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
150 | $74,509 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
1,446 | $51,173 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
112 | $20,975 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32 | $19,953 | |
| 5 | ARGX |
Argenx SE
|
20 | $18,555 | |
| 6 | INCY |
Incyte Corp
|
156 | $17,684 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
223 | $16,609 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
49 | $14,750 |
All Filings in KRYS
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,946 | 16 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $4,133 | 16 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,944 | 16 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $2,824 | 16 | Shares | Sole | 2025-11-21 | |
| 2025-06-30 | $2,611 | 19 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,425 | 19 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $4,386 | 28 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,458 | 19 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,387 | 13 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,491 | 14 | Shares | Sole | 2024-05-08 | |
| 2023-09-30 | $464 | 4 | Shares | Sole | 2023-11-08 | |
| 2021-12-31 | $629 | 9 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||